further agreed that if such use is planned, the purchaser will 

 first obtain prior written approval of the Project Officer, 

 NOl-GM-6-2119, National Institute of General Medical Sciences. 



This agreement, when appropriately executed, will be on file 

 and will qualify you to receive lymphoid and virus transformed 

 cell lines from the Human Genetic Mutant Cell Repository. 



AGREEMENT ON LYMPHOID AND VIRUS TRANSFORMED CELLS 



We the signatories below, have read and understand this 

 document and agree that in the handling of cell lines furnished, 

 we will adhere to the procedures and recommendations outlined in 

 the foregoing and the attached "Minimum Safety Guidelines 

 Recommended for Working with Lymphoid and Virus Transformed 

 Human Cell Lines." 



A. For the recipient laboratory: 



Investigator: Signature Date 



Title 



Head of Signature Date 



Laboratory or 



Immediate Title 



Supervisor : 



Address 



B. For Human Genetic Mutant Cell Repository: 



Signature Date 



Title 



11 



